参考文献
2020-10-19
1: Cassetta L, Pollard JW. Repolarizing macrophages improves breast cancer
therapy. Cell Res. 2017 Apr 21. doi: 10.1038/cr.2017.63. [Epub ahead of print]
PubMed PMID: 28429765.
2: Targeting Class IIa HDACs May Suppress Breast Tumors and Metastases. Cancer
Discov. 2017 Mar 17. doi: 10.1158/2159-8290.CD-RW2017-053. [Epub ahead of print]
PubMed PMID: 28314719.
3: Guerriero JL, Sotayo A, Ponichtera HE, Castrillon JA, Pourzia AL, Schad S,
Johnson SF, Carrasco RD, Lazo S, Bronson RT, Davis SP, Lobera M, Nolan MA, Letai
A. Class IIa HDAC inhibition reduces breast tumours and metastases through
anti-tumour macrophages. Nature. 2017 Mar 16;543(7645):428-432. doi:
10.1038/nature21409. Epub 2017 Mar 8. PubMed PMID: 28273064.
